About UPM Biochemicals
UPM Biochemicals is a Chemicals & Materials company based in Helsinki (Finland) founded in 1996. UPM Biochemicals has completed 1 acquisition, including SunCoal. Its chief executive, as recorded, is Jussi Pesonen. UPM Biochemicals offers products and services including Bio-Monoethylene Glycol, Bio-Monopropylene Glycol, Renewable Functional Fillers, Lignin Solutions, and Industrial Sugar. Its focus areas include Chemicals and Materials Tech, Chemicals Tech, Green Chemicals and Diversified. Its legal entity is UPM-Kymmene Oyj.
Company details
Wood-based biochemical manufacturer. Its applications are in replacing fossil-raw materials, forestry, climate neutral feedstock, and glycol production.
- Headquarters Helsinki, Finland
- SectorsChemicals & Materials
- Phone•••• ••••
- Website upmbiochemicals.com
- Social LinkedIn X
- Legal Name Upm-Kymmene Oyj
- Annual Revenue$2.08 B (USD)26as on Dec 31, 2022
- Net Profit$1.64 B (USD)19as on Dec 31, 2022
- EBITDA$2.05 B (USD)26as on Dec 31, 2022
- Latest Funding Round$14.46M (USD), Grant
Dec 2022
- Investors
- Investments & Acquisitions
Products & Services of UPM Biochemicals
UPM Biochemicals offers a comprehensive portfolio of products and services, including Bio-Monoethylene Glycol, Bio-Monopropylene Glycol, Renewable Functional Fillers, Lignin Solutions, and Industrial Sugar.
Ethylene glycol derived from wood for industrial applications.
Propylene glycol from sustainable sources for various uses.
Fillers made from renewable sources to enhance product performance.
Lignin-based products for integration into production processes.
Sugar derived from wood for industrial and biochemical applications.
Funding Insights of UPM Biochemicals
- Total Rounds 1
- Last Round Grant — $14.46M
- First Round $14.46M
(Dec 2022)
- Investors Count 1
All 1 funding rounds of UPM Biochemicals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $14.46M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in UPM Biochemicals
UPM Biochemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for UPM Biochemicals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of UPM Biochemicals
2 people are tracked at UPM Biochemicals (2 in leadership).
| Name | Role | Group |
|---|---|---|
Jussi Pesonen | Co-CEO | Leadership |
Massimo Reynaudo | Co-CEO | Leadership |
Complete people profiles for UPM Biochemicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by UPM Biochemicals
UPM Biochemicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SunCoal.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Development and validation services for pharmaceuticals are provided by SunCoal. | suncoal.com | Ludwigsfelde, Germany | 2007 | Aug 2023 | •••• |
Complete acquisition details for UPM Biochemicals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of UPM Biochemicals
3 dated milestones of UPM Biochemicals across 27 years, from founding to its latest funding, stage changes and deals.
- Founded UPM Biochemicals is founded.
- Funding First funding round of $14.5M.
- Acquisition Acquires SunCoal.
Web traffic of UPM Biochemicals
The website of UPM Biochemicals (upmbiochemicals.com) receives about 4.3K visits a month.
- Monthly visits4.3K
▼ 7.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Upm Biochemicals
Complete news archive for UPM Biochemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UPM Biochemicals
UPM Biochemicals was founded in 1996 and raised its 1st funding round 26 years after it was founded.
UPM Biochemicals is headquartered in Helsinki, Finland.
Jussi Pesonen is the CEO of UPM Biochemicals, as recorded in our data.
Annual revenue of UPM Biochemicals is $2.08B as on Dec 31, 2022.
Wood-based biochemical manufacturer. Its applications are in replacing fossil-raw materials, forestry, climate neutral feedstock, and glycol production.
UPM Biochemicals offers Bio-Monoethylene Glycol, Bio-Monopropylene Glycol, Renewable Functional Fillers, Lignin Solutions, and Industrial Sugar.
UPM Biochemicals has made 1 acquisition, including SunCoal.
UPM Biochemicals has 1 investor. Key investors include European Union.
UPM Biochemicals operates through Upm-Kymmene Oyj.